Biodesix, Inc. EPS (Diluted, Consolidated)

EPS (Diluted, Consolidated) of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted, Consolidated) growth rates and interactive chart.

Highlights and Quick Summary

  • EPS (Diluted, Consolidated) for the quarter ending September 30, 2022 was $-0.339 (a -16.02% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted, Consolidated) decreased by -31.42%
  • Annual EPS (Diluted, Consolidated) for 2021 was $-1.58 (a -75.66% decrease from previous year)
  • Annual EPS (Diluted, Consolidated) for 2020 was $-6.48 (a -94.9% decrease from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted, Consolidated) of Biodesix, Inc.

Most recent EPS (Diluted, Consolidated)of BDSX including historical data for past 10 years.

Interactive Chart of EPS (Diluted, Consolidated) of Biodesix, Inc.

Biodesix, Inc. EPS (Diluted, Consolidated) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $0.0 $0.0
2021 $0.0 $0.0 $0.0 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0 $0.0
2019 $0.0 $0.0

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research